Detalles de la búsqueda
1.
Lung Oligometastasis of Breast Cancer: Prospective Cohort Study of Treatment Strategies (SBP-06).
Acta Med Okayama;
78(1): 15-20, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38419310
2.
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy.
Breast Cancer Res Treat;
199(2): 231-241, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36947277
3.
Gradient Boosted Tree Approaches for Mapping European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Onto 5-Level Version of EQ-5D Index for Patients With Cancer.
Value Health;
26(2): 269-279, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096966
4.
Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L.
Health Qual Life Outcomes;
21(1): 3, 2023 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36650539
5.
Safety and Efficacy of a Well-Fitting Brassiere after Breast Reconstruction: A Qualitative Study.
Acta Med Okayama;
77(1): 11-19, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849141
6.
Impact of Immediate Breast Reconstruction on Survival of Breast Cancer Patients: A Single-Center Observational Study.
Acta Med Okayama;
77(3): 281-290, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37357629
7.
An observational study of the impact of immediate breast reconstruction on perioperative inflammatory cytokines.
Surg Today;
53(11): 1305-1316, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212931
8.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Lancet Oncol;
23(5): 636-649, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405087
9.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci;
113(9): 3169-3179, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35754298
10.
Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two randomized clinical trials.
Support Care Cancer;
30(10): 8367-8375, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35857127
11.
Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial.
Qual Life Res;
31(6): 1829-1836, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34982354
12.
Gene Expression Profiling between Patient Groups with High and Low Ki67 Levels after Short-term Preoperative Aromatase Inhibitor Treatment for Breast Cancer.
Acta Med Okayama;
76(4): 399-408, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36123154
13.
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.
Acta Med Okayama;
76(6): 661-671, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36549768
14.
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial.
Breast Cancer Res Treat;
188(3): 675-683, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34080094
15.
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
Breast Cancer Res Treat;
185(2): 307-316, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33034801
16.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Acta Med Okayama;
75(3): 357-362, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176940
17.
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development.
Int J Mol Sci;
22(23)2021 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34884609
18.
Response Shift-Adjusted Treatment Effect on Health-Related Quality of Life in a Randomized Controlled Trial of Taxane Versus S-1 for Metastatic Breast Cancer: Structural Equation Modeling.
Value Health;
23(6): 768-774, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32540235
19.
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
Health Qual Life Outcomes;
18(1): 354, 2020 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33143687
20.
Evaluation of Prognosis of Juvenile Differentiated Thyroid Carcinoma.
Acta Med Okayama;
74(5): 401-406, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33106695